Is Infliximab Effective for Induction of Remission in Patients with Ulcerative Colitis?
Open Access
- 1 May 2001
- journal article
- editorial
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 7 (2) , 89-93
- https://doi.org/10.1097/00054725-200105000-00002
Abstract
Crohn’s disease (CD) and ulcerative colitis (UC) constitute distinct yet somewhat similar idiopathic inflammatory disorders of the gastrointestinal tract. ManifKeywords
This publication has 33 references indexed in Scilit:
- Medical Therapy for Crohn's Disease: The State of the ArtSurgical Clinics of North America, 2001
- Chemokines and cytokines in inflammatory bowel disease and their application to disease treatmentCurrent Opinion in Gastroenterology, 2000
- Synergistic effects of interferon γ and tumour necrosis factor α on T84 cell functionGut, 1999
- NOVEL THERAPIES FOR INFLAMMATORY BOWEL DISEASEGastroenterology Clinics of North America, 1999
- Mast cells are an important cellular source of tumour necrosis factor α in human intestinal tissueGut, 1999
- Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosaGut, 1999
- Tumor necrosis factor alpha regulates proliferation in a mouse intestinal cell lineGastroenterology, 1997
- Effect of tumor necrosis factor‐α and interferon‐γ on the growth of a human salivary gland cell lineJournal of Cellular Physiology, 1994
- Differential cytokine expression by human intestinal epithelial cell lines: Regulated expression of interleukin 8Gastroenterology, 1993
- Renal allograft rejection: expression and function of VCAM-1 on tubular epithelial cellsClinical and Experimental Immunology, 1993